Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Legal

USA. Purdue Pharma Settlement a “Stopgap” For Areas Hardest Hit by Opioid Crisis: Report

USA. Purdue Pharma Settlement a “Stopgap” For Areas Hardest Hit by Opioid Crisis: Report

The proposed settlement with OxyContin maker Purdue Pharma is “no more than a stopgap for local and state governments,” which will continue to face costs related to the opioid crisis that far exceed the agreed upon amounts, according to a new report by Moody’s Investors Services. (Partnership News Service Staff, USA, 26.09.2019)

https://drugfree.org/learn/drug-and-alcohol-news/purdue-pharma-settlement-a-stopgap-for-areas-hardest-hit-by-opioid-crisis-report